Dartmouth Tuberculosis Vaccine Passes Important Milestone
Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
Source: News at Dartmouth Medical School - Category: Hospital Management Authors: Geisel Communications Tags: News DAR-901 DarDar Features Ford Von Reyn global health research TB tuberculosis vaccine Source Type: news
More News: Hospital Management | Infectious Diseases | Study | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines